Robert Thimme

Robert Thimme's AcademicInfluence.com Rankings

Robert Thimme

Biology

#8146

World Rank

#11180

Historical Rank

Virology

#175

World Rank

#180

Historical Rank

Immunology

#459

World Rank

#476

Historical Rank

biology Degrees

Download Badge

Biology

Why Is Robert Thimme Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Robert Thimme's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Determinants of Viral Clearance and Persistence during Acute Hepatitis C Virus Infection (2001) (1261)
CD8+ T Cells Mediate Viral Clearance and Disease Pathogenesis during Acute Hepatitis B Virus Infection (2003) (889)
Genomic analysis of the host response to hepatitis C virus infection (2002) (846)
Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease (2002) (693)
Autosomal-dominant immune dysregulation syndrome in humans with CTLA4 mutations (2014) (672)
Regulated expression of nuclear receptor RORγt confers distinct functional fates to NK cell receptor-expressing RORγt(+) innate lymphocytes. (2010) (621)
T Cell Factor 1-Expressing Memory-like CD8(+) T Cells Sustain the Immune Response to Chronic Viral Infections. (2016) (590)
Natural history of chronic hepatitis B virus infection (2015) (565)
Genomic analysis of the host response to hepatitis B virus infection. (2004) (557)
TOX reinforces the phenotype and longevity of exhausted T cells in chronic viral infection (2019) (443)
T Cells with a CD4+CD25+ Regulatory Phenotype Suppress In Vitro Proliferation of Virus-Specific CD8+ T Cells during Chronic Hepatitis C Virus Infection (2005) (438)
Coexpression of PD-1, 2B4, CD160 and KLRG1 on Exhausted HCV-Specific CD8+ T Cells Is Linked to Antigen Recognition and T Cell Differentiation (2010) (381)
Differential CD4+ and CD8+ T‐cell responsiveness in hepatitis C virus infection (2001) (364)
A lymphotoxin-driven pathway to hepatocellular carcinoma. (2009) (350)
Analysis of CD161 expression on human CD8+ T cells defines a distinct functional subset with tissue-homing properties (2010) (341)
Pathogenesis of hepatitis B virus infection. (2007) (308)
Immunodominance and functional alterations of tumor‐associated antigen‐specific CD8+ T‐cell responses in hepatocellular carcinoma (2014) (272)
A global scientific strategy to cure hepatitis B. (2019) (253)
The ALBI grade provides objective hepatic reserve estimation across each BCLC stage of hepatocellular carcinoma. (2017) (248)
Innate and adaptive immune responses in HCV infections. (2014) (243)
Characterization of pre-existing and induced SARS-CoV-2-specific CD8+ T cells (2020) (236)
Induction of MxA Gene Expression by Influenza A Virus Requires Type I or Type III Interferon Signaling (2007) (230)
Interferon-γ and Tumor Necrosis Factor-α Produced by T Cells Reduce the HBV Persistence Form, cccDNA, Without Cytolysis. (2016) (230)
Dominant influence of an HLA‐B27 restricted CD8+ T cell response in mediating HCV clearance and evolution (2006) (224)
Restoration of HCV-specific CD8+ T cell function by interferon-free therapy. (2014) (222)
Expansion and contraction of the hepatitis B virus transcriptional template in infected chimpanzees (2004) (213)
Colonoscopic full-thickness resection using an over-the-scope device: a prospective multicentre study in various indications (2017) (206)
Restoration of HBV-specific CD8+ T cell function by PD-1 blockade in inactive carrier patients is linked to T cell differentiation. (2014) (203)
Expression of the Interleukin-7 Receptor Alpha Chain (CD127) on Virus-Specific CD8+ T Cells Identifies Functionally and Phenotypically Defined Memory T Cells during Acute Resolving Hepatitis B Virus Infection (2006) (201)
Rapid and stable mobilization of CD8+ T cells by SARS-CoV-2 mRNA vaccine (2021) (200)
Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells (2018) (187)
Functional classification of memory CD8+ T cells by CX3CR1 expression (2015) (185)
Hepatic immune regulation and its involvement in viral hepatitis infection. (2014) (176)
Intrahepatic CD8+ T‐cell failure during chronic hepatitis C virus infection (2005) (173)
Antiviral and Regulatory T Cell Immunity in a Patient with Stromal Interaction Molecule 1 Deficiency (2012) (172)
Hepatitis C virus lacking the hypervariable region 1 of the second envelope protein is infectious and causes acute resolving or persistent infection in chimpanzees. (2000) (171)
Increased Expression of the NK Cell Receptor KLRG1 by Virus-Specific CD8 T Cells during Persistent Antigen Stimulation (2005) (171)
TCF1+ hepatitis C virus-specific CD8+ T cells are maintained after cessation of chronic antigen stimulation (2017) (161)
Human Th17 Cells Express High Levels of Enzymatically Active Dipeptidylpeptidase IV (CD26) (2012) (154)
T cell responses in hepatitis C: the good, the bad and the unconventional (2011) (146)
Auto-aggressive CXCR6+ CD8 T cells cause liver immune pathology in NASH (2021) (140)
Failure of innate and adaptive immune responses in controlling hepatitis C virus infection. (2012) (139)
Deep spatial profiling of human COVID-19 brains reveals neuroinflammation with distinct microanatomical microglia-T-cell interactions (2021) (139)
T cell response in hepatitis C virus infection. (2005) (138)
Hepatitis C virus-induced hepatocarcinogenesis. (2009) (137)
Analysis of CD127 and KLRG1 Expression on Hepatitis C Virus-Specific CD8+ T Cells Reveals the Existence of Different Memory T-Cell Subsets in the Peripheral Blood and Liver (2006) (135)
A target on the move: innate and adaptive immune escape strategies of hepatitis C virus. (2006) (135)
Virological and immunological determinants of intrahepatic virus‐specific CD8+ T‐cell failure in chronic hepatitis C virus infection (2008) (134)
Loss of viral fitness and cross-recognition by CD8+ T cells limit HCV escape from a protective HLA-B27-restricted human immune response. (2009) (128)
GALAD Score Detects Early Hepatocellular Carcinoma in an International Cohort of Patients With Nonalcoholic Steatohepatitis. (2019) (120)
HBV life cycle and novel drug targets (2011) (117)
Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy: Considerations for scientists and funding agencies. (2018) (117)
Potential of immunotherapy for hepatocellular carcinoma. (2011) (115)
Uptake and presentation of hepatitis C virus-like particles by human dendritic cells. (2005) (106)
Comprehensive Intestinal T Helper Cell Profiling Reveals Specific Accumulation of IFN-&ggr;+IL-17+Coproducing CD4+ T Cells in Active Inflammatory Bowel Disease (2014) (105)
Dissecting the divergent effects of interferon-alpha on immune cells: time to rethink combination therapy in chronic hepatitis B? (2013) (102)
Scavenger Receptor Class B Is Required for Hepatitis C Virus Uptake and Cross-Presentation by Human Dendritic Cells (2008) (99)
Phenotypic and functional differences of HBV core-specific versus HBV polymerase-specific CD8+ T cells in chronically HBV-infected patients with low viral load (2019) (98)
Analysis of CD8+ T-cell-mediated inhibition of hepatitis C virus replication using a novel immunological model. (2009) (96)
CD161 expression on hepatitis C virus–specific CD8+ T cells suggests a distinct pathway of T cell differentiation (2008) (94)
Previously Infected Chimpanzees Are Not Consistently Protected against Reinfection or Persistent Infection after Reexposure to the Identical Hepatitis C Virus Strain (2008) (92)
Dysfunctional CD8+ T cells in hepatitis B and C are characterized by a lack of antigen-specific T-bet induction (2014) (92)
Transfusion-transmitted hepatitis E in Germany, 2013. (2014) (88)
Inhibitory molecules that regulate expansion and restoration of HCV-specific CD4+ T cells in patients with chronic infection. (2011) (87)
Within-host evolution of SARS-CoV-2 in an immunosuppressed COVID-19 patient as a source of immune escape variants (2021) (85)
MiR-146a regulates the TRAF6/TNF-axis in donor T cells during GVHD. (2014) (84)
Insights From Antiviral Therapy Into Immune Responses to Hepatitis B and C Virus Infection. (2019) (82)
Parallel Expansion of Human Virus-Specific FoxP3− Effector Memory and De Novo-Generated FoxP3+ Regulatory CD8+ T Cells upon Antigen Recognition In Vitro1 (2007) (80)
Hepatitis C Virus (HCV) Sequence Variation Induces an HCV-Specific T-Cell Phenotype Analogous to Spontaneous Resolution (2009) (79)
Tracking Virus-Specific CD4+ T Cells during and after Acute Hepatitis C Virus Infection (2007) (78)
Endoscopic full-thickness resection for early colorectal cancer. (2019) (76)
T-cell responses in hepatitis B and C virus infection: similarities and differences (2013) (73)
Serum markers of hepatocellular carcinoma. (2006) (71)
Analysis of the Evolutionary Forces in an Immunodominant CD8 Epitope in Hepatitis C Virus at a Population Level (2008) (70)
Targeted therapy for hepatocellular carcinoma (2009) (70)
Memory-like HCV-specific CD8+ T cells retain a molecular scar after cure of chronic HCV infection (2021) (69)
The Role of Natural Killer Cells and CD8+ T Cells in Hepatitis B Virus Infection (2014) (68)
Analysis of CD8+ T cell-mediated inhibition of hepatitis C virus replication using a novel immunological model (2009) (67)
Adaptive immune responses in hepatitis C virus infection. (2013) (66)
Regulatory T cells in viral hepatitis. (2007) (65)
Comprehensive analysis of the α‐fetoprotein‐specific CD8+ T cell responses in patients with hepatocellular carcinoma (2008) (65)
T Cells with a CD 4 CD 25 Regulatory Phenotype Suppress In Vitro Proliferation of Virus-Specific CD 8 T Cells during Chronic Hepatitis C Virus Infection (2005) (64)
Diarrhea predicts a positive response to sorafenib in patients with advanced hepatocellular carcinoma (2012) (64)
Protective effect of human leukocyte antigen B27 in hepatitis C virus infection requires the presence of a genotype‐specific immunodominant CD8+ T‐cell epitope (2010) (61)
Virus-Specific CD4+ T Cells Have Functional and Phenotypic Characteristics of Follicular T-Helper Cells in Patients With Acute and Chronic HCV Infections. (2016) (59)
Secretion of Hepatitis C Virus Replication Intermediates Reduces Activation of Toll-Like Receptor 3 in Hepatocytes. (2018) (58)
Immunodominance of HLA-A2-Restricted Hepatitis C Virus-Specific CD8+ T Cell Responses Is Linked to Naïve-Precursor Frequency (2011) (58)
First-line endoscopic treatment with over-the-scope clips significantly improves the primary failure and rebleeding rates in high-risk gastrointestinal bleeding: A single-center experience with 100 cases (2016) (58)
Treatment with proton pump inhibitors increases the risk of secondary infections and ARDS in hospitalized patients with COVID‐19: coincidence or underestimated risk factor? (2020) (57)
Prolonged SARS-CoV-2 shedding and mild course of COVID-19 in a patient after recent heart transplantation (2020) (56)
Escape from HLA-B*08-Restricted CD8 T Cells by Hepatitis C Virus Is Associated with Fitness Costs (2008) (56)
Adaptive immune responses to hepatitis C virus: from viral immunobiology to a vaccine (2008) (54)
β2-Microglobulin deficiency causes a complex immunodeficiency of the innate and adaptive immune system. (2015) (53)
The Burden of Hepatitis E among Patients with Hematological Malignancies: a Retrospective European Cohort Study. (2019) (52)
In Vivo Study of the HC-TN Strain of Hepatitis C Virus Recovered from a Patient with Fulminant Hepatitis: RNA Transcripts of a Molecular Clone (pHC-TN) Are Infectious in Chimpanzees but Not in Huh7.5 Cells (2007) (51)
Human leukocyte antigen B27 selects for rare escape mutations that significantly impair hepatitis C virus replication and require compensatory mutations (2011) (51)
OX40 stimulation and PD-L1 blockade synergistically augment HBV-specific CD4 T cells in patients with HBeAg-negative infection. (2019) (50)
Active Maintenance of T Cell Memory in Acute and Chronic Viral Infection Depends on Continuous Expression of FOXO1. (2018) (50)
Host and viral factors contributing to CD8+ T cell failure in hepatitis C virus infection. (2007) (50)
Mx1 but not MxA confers resistance against tick-borne Dhori virus in mice. (1995) (49)
[ALT screening for chronic liver diseases: scrutinizing the evidence]. (2010) (49)
Abnormally differentiated CD4+ or CD8+ T cells with phenotypic and genetic features of double negative T cells in human Fas deficiency. (2014) (48)
Tuning a cellular lipid kinase activity adapts hepatitis C virus to replication in cell culture (2016) (48)
On‐target sorafenib toxicity predicts improved survival in hepatocellular carcinoma: a multi‐centre, prospective study (2017) (47)
Improved responses to pegylated interferon alfa-2b and ribavirin by individualizing treatment for 24-72 weeks. (2011) (47)
Bystander hyperactivation of preimmune CD8+ T cells in chronic HCV patients (2015) (47)
Full-Thickness-Resection-Device (FTRD) (2015) (46)
Procedural and shunt‐related complications and mortality of the transjugular intrahepatic portosystemic shunt (TIPSS) (2016) (44)
Rapid and simple detection of IFN‐neutralizing antibodies in chronic hepatitis C non‐responsive to IFN‐α (2006) (43)
The transcription factor c-Jun/AP-1 promotes liver fibrosis during non-alcoholic steatohepatitis by regulating Osteopontin expression (2019) (43)
Factors that determine the antiviral efficacy of HCV-specific CD8(+) T cells ex vivo. (2013) (42)
Safety and immunogenicity of the therapeutic vaccine TG1050 in chronic hepatitis B patients: a phase 1b placebo-controlled trial (2019) (41)
Excellent local control and tolerance profile after stereotactic body radiotherapy of advanced hepatocellular carcinoma (2017) (41)
The transcription factor c-JUN/AP-1 promotes HBV-related liver tumorigenesis in mice (2013) (41)
Rapid and strong antiviral activity of the non-nucleosidic NS5B polymerase inhibitor BI 207127 in combination with peginterferon alfa 2a and ribavirin. (2012) (41)
Unique and Common Features of Innate-Like Human Vδ2+ γδT Cells and Mucosal-Associated Invariant T Cells (2018) (39)
SARS-CoV-2 vaccination can elicit a CD8 T-cell dominant hepatitis (2022) (39)
CD8+ regulatory T cells in persistent human viral infections. (2008) (39)
IL-33 expression in response to SARS-CoV-2 correlates with seropositivity in COVID-19 convalescent individuals (2020) (39)
Refining prediction of survival after TIPS with the novel Freiburg index of post-TIPS survival. (2021) (39)
The albumin–bilirubin grade improves hepatic reserve estimation post‐sorafenib failure: implications for drug development (2017) (36)
Cellular Immune Responses to Hepatocellular Carcinoma: Lessons for Immunotherapy (2012) (36)
Impact of the genetic restriction of virus-specific T-cell responses in hepatitis C virus infection (2007) (35)
TOX defines the degree of CD8+ T cell dysfunction in distinct phases of chronic HBV infection (2020) (35)
Identification of CD4 T-cell epitopes in soluble liver antigen/liver pancreas autoantigen in autoimmune hepatitis. (2008) (35)
Efficacy and safety of transjugular intrahepatic portosystemic shunt (TIPSS) in 40 patients with hepatocellular carcinoma (2015) (35)
Immune-surveillance through exhausted effector T-cells. (2016) (34)
Hepatitis B or hepatitis C and human immunodeficiency virus infection. (2005) (34)
Identification of Five Different Patr Class I Molecules That Bind HLA Supertype Peptides and Definition of Their Peptide Binding Motifs1 (2000) (34)
Degenerate Immunogenicity of an HLA-A2-Restricted Hepatitis B Virus Nucleocapsid Cytotoxic T-Lymphocyte Epitope That Is Also Presented by HLA-B51 (2001) (34)
Role of Host Genetic Factors in the Outcome of Hepatitis C Virus Infection (2009) (33)
HCV-Specific T Cell Responses During and After Chronic HCV Infection (2018) (33)
Heterogeneity of HBV-Specific CD8+ T-Cell Failure: Implications for Immunotherapy (2019) (32)
Hepatitis C virus recombinants are rare even among intravenous drug users (2010) (32)
Hepatitis B virus: from immunobiology to immunotherapy. (2013) (32)
Chronic Hepatitis E in Rheumatology and Internal Medicine Patients: A Retrospective Multicenter European Cohort Study (2019) (31)
Follicular T helper cells shape the HCV-specific CD4 T cell repertoire after viral elimination. (2019) (31)
CD161+CD4+ T cells are enriched in the liver during chronic hepatitis and associated with co-secretion of IL-22 and IFN-γ (2012) (31)
CD8+ T-Cell Responses in Hepatitis B and C: The (HLA-) A, B, and C of Hepatitis B and C (2016) (30)
Mutations in Hepatitis D Virus Allow It to Escape Detection by CD8+ T Cells and Evolve at the Population Level (2019) (30)
Immunological cure of HBV infection (2019) (30)
Success and Failure of Virus-Specific T Cell Responses in Hepatitis C Virus Infection (2011) (29)
HLA-B*27 subtype specificity determines targeting and viral evolution of a hepatitis C virus-specific CD8+ T cell epitope. (2014) (29)
Rapid and simple detection of IFN-neutralizing antibodies in chronic hepatitis C non-responsive to IFN-alpha. (2006) (29)
NK-cell responses are biased towards CD16-mediated effector functions in chronic hepatitis B virus infection. (2019) (28)
Compensatory Mutations Restore the Replication Defects Caused by Cytotoxic T Lymphocyte Escape Mutations in Hepatitis C Virus Polymerase (2011) (28)
Stereotactic Body Radiation Therapy as an Alternative Treatment for Patients with Hepatocellular Carcinoma Compared to Sorafenib: A Propensity Score Analysis (2018) (27)
Experimental models to study the immunobiology of hepatitis C virus. (2011) (26)
MMP2/MMP9-mediated CD100 shedding is crucial for inducing intrahepatic anti-HBV CD8 T cell responses and HBV clearance. (2019) (26)
Rapid Antigen Processing and Presentation of a Protective and Immunodominant HLA-B*27-restricted Hepatitis C Virus-specific CD8+ T-cell Epitope (2012) (26)
Absence of viral escape within a frequently recognized HLA-A26-restricted CD8+ T-cell epitope targeting the functionally constrained hepatitis C virus NS5A/5B cleavage site. (2007) (26)
Vitamin D inhibits pro-inflammatory T cell function in patients with inflammatory bowel disease. (2019) (26)
Differential antigen specificity of hepatitis C virus-specific interleukin 17- and interferon γ-producing CD8(+) T cells during chronic infection. (2012) (25)
Lack of ex vivo peripheral and intrahepatic α‐fetoprotein‐specific CD4+ responses in hepatocellular carcinoma (2011) (24)
Overcoming CD8+ T-Cell Exhaustion in Viral Hepatitis: Lessons from the Mouse Model and Clinical Perspectives (2017) (24)
Hepatitis B Virus-Infected HepG2hNTCP Cells Serve as a Novel Immunological Tool To Analyze the Antiviral Efficacy of CD8+ T Cells In Vitro (2015) (24)
Virus-specific CD4+ T cell responses in chronic HCV infection in blood and liver identified by antigen-specific upregulation of CD154. (2010) (23)
Comparison of local tumor control in patients with HCC treated with SBRT or TACE: a propensity score analysis (2018) (22)
Immunobiology of hepatocellular carcinoma (2012) (22)
Evolving therapies in the treatment of hepatocellular carcinoma (2008) (22)
TGF‐β downregulates KLRG1 expression in mouse and human CD8+ T cells (2015) (22)
Hepitopes: A live interactive database of HLA class I epitopes in hepatitis B virus (2016) (22)
Host cell responses induced by hepatitis C virus binding (2006) (21)
Perspectives of immunotherapy in hepatocellular carcinoma (HCC) (2016) (21)
[Hepatic resection for hepatocellular carcinoma--results and analysis of the current literature]. (2009) (21)
T cell exhaustion and residency dynamics inform clinical outcomes in hepatocellular carcinoma. (2022) (21)
Host genetics in immune-mediated hepatitis C virus clearance. (2011) (21)
Analysis of bulk and virus-specific CD8+ T cells reveals advanced differentiation of CD8+ T cells in patients with common variable immunodeficiency. (2011) (21)
CD40 inhibits replication of hepatitis C virus in primary human hepatocytes by c‐jun N terminal kinase activation independent from the interferon pathway (2013) (20)
The role of albumin–bilirubin grade and inflammation-based index in patients with hepatocellular carcinoma treated with stereotactic body radiotherapy (2018) (20)
In vivo proof of concept of adoptive immunotherapy for hepatocellular carcinoma using allogeneic suicide gene-modified killer cells. (2014) (20)
A prospective, multicentre study in acute non‐cirrhotic, non‐malignant portal vein thrombosis: comparison of medical and interventional treatment (2020) (20)
Treatment Stage Migration Maximizes Survival Outcomes in Patients with Hepatocellular Carcinoma Treated with Sorafenib: An Observational Study (2017) (20)
Bridging basic science and clinical research: the EASL Monothematic Conference on Translational Research in Viral Hepatitis. (2014) (20)
First report of invasive liver abscess syndrome with endophthalmitis caused by a K2 serotype ST2398 hypervirulent Klebsiella pneumoniae in Germany, 2016 (2017) (19)
Extracellular ATP and purinergic P2Y2 receptor signaling promote liver tumorigenesis in mice by exacerbating DNA damage. (2019) (19)
Tetramer Enrichment Reveals the Presence of Phenotypically Diverse Hepatitis C Virus-Specific CD8+ T Cells in Chronic Infection (2014) (19)
Role of Immunity in Pathogenesis and Treatment of Hepatocellular Carcinoma (2016) (19)
Synergism of tapasin and human leukocyte antigens in resolving hepatitis C virus infection (2013) (19)
Tumor-associated antigen specific CD8+ T cells in hepatocellular carcinoma – a promising target for immunotherapy (2014) (19)
Low perforin expression of early differentiated HCV-specific CD8+ T cells limits their hepatotoxic potential. (2012) (18)
T cell immunity to hepatitis C virus: lessons for a prophylactic HCV vaccine. (2020) (18)
Survival benefit of transarterial chemoembolization in patients with metastatic hepatocellular carcinoma: a single center experience (2017) (18)
Selenium levels in patients with hepatitis C virus‐related chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma: A pilot study (2013) (18)
Treatment with proton pump inhibitors increases the risk for development of hepatic encephalopathy after implantation of transjugular intrahepatic portosystemic shunt (TIPS) (2018) (17)
Treatment with proton pump inhibitors is associated with increased mortality in patients with pyogenic liver abscess (2018) (17)
COVID-19 mRNA booster vaccine induces transient CD8+ T effector cell responses while conserving the memory pool for subsequent reactivation (2022) (17)
Vitamin D Levels Vary during Antiviral Treatment but Are Unable to Predict Treatment Outcome in HCV Genotype 1 Infected Patients (2014) (17)
Chronic hepatitis E virus infection following allogeneic hematopoietic stem cell transplantation: an important differential diagnosis for graft versus host disease (2015) (17)
[COVID-19 associated pneumonia despite repeatedly negative PCR-analysis from oropharyngeal swabs]. (2020) (16)
SARS-CoV-2-specific T-cell epitope repertoire in convalescent and mRNA-vaccinated individuals (2022) (16)
Pre-existing immunity and vaccine history determine hemagglutinin-specific CD4 T cell and IgG response following seasonal influenza vaccination (2021) (16)
[Pyogenic liver abscess: Changes of Organisms and Consequences for Diagnosis and Therapy]. (2017) (15)
Natural killer cells and hepatitis C: Natural killer p46 expression linked to antiviral and antifibrotic activity (2012) (15)
CD8+ T Cell Responses during HCV Infection and HCC (2021) (15)
Hepatitis C virus-induced natural killer cell proliferation involves monocyte-derived cells and the OX40/OX40L axis. (2017) (15)
Suppressive effect of interleukin 10 on priming of naive hepatitis C virus-specific CD8+ T cells. (2015) (14)
2007 4 WEEK THERAPY WITH THE NON-NUCLEOSIDIC POLYMERASE INHIBITOR BI207127 IN COMBINATION WITH PEGINTERFERON-ALFA2A AND RIBAVIRIN IN TREATMENT NAIVE AND TREATMENT EXPERIENCED CHRONIC HCV GT1 PATIENTS (2010) (14)
Advances in prevention and diagnosis of hepatocellular carcinoma (2008) (14)
Vacuum sponge therapy using the pull-through technique via a percutaneous endoscopic gastrostomy to treat iatrogenic duodenal perforation (2015) (14)
IL-2 contributes to cirrhosis-associated immune dysfunction by impairing follicular T helper cells in advanced cirrhosis. (2020) (14)
Acute pancreatitis and vasoplegic shock associated with leptospirosis – a case report and review of the literature (2019) (14)
Ampullary Hamartoma: A Rare Cause of Biliary Obstruction (1999) (14)
Inefficient induction of circulating TAA-specific CD8+ T-cell responses in hepatocellular carcinoma (2019) (13)
Serum protein profiling reveals a specific upregulation of the immunomodulatory protein progranulin in COVID-19 (2020) (13)
Impact of age on sorafenib outcomes in hepatocellular carcinoma: an international cohort study (2020) (13)
Determinants of in vitro expansion of different human virus-specific FoxP3+ regulatory CD8+ T cells in chronic hepatitis C virus infection. (2009) (13)
Ex vivo detection of SARS-CoV-2-specific CD8+ T cells: rapid induction, prolonged contraction, and formation of functional memory (2020) (13)
Two-sided sponge (TSS) treatment: Description of a novel device and technique for endoscopic vacuum treatment (EVT) in the upper gastrointestinal tract (2016) (12)
Adaptive Immune Response against Hepatitis C Virus (2020) (12)
Ustekinumab Inhibits T Follicular Helper Cell Differentiation in Patients With Crohn’s Disease (2020) (12)
Nonsurgical Therapeutic Options in Portal Vein Thrombosis (2014) (12)
Follicular T Helper Cell Signatures in Primary Biliary Cholangitis and Primary Sclerosing Cholangitis (2018) (12)
Efficacy of Retreatment After Failed Direct-acting Antiviral Therapy in Patients With HCV Genotype 1-3 Infections. (2019) (12)
Case Series: Convalescent Plasma Therapy for Patients with COVID-19 and Primary Antibody Deficiency (2021) (12)
31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two (2016) (11)
Sexual dimorphism in hepatitis B and C and hepatocellular carcinoma (2018) (11)
Entering the spotlight: hepatitis B surface antigen-specific B cells. (2018) (11)
Interleukin-10 and viral clearance: translation to viral hepatitis. (2007) (11)
ERAP1 allotypes shape the epitope repertoire of virus-specific CD8+ T cell responses in acute hepatitis C virus infection (2019) (11)
[Perspectives on immunotherapy for hepatocellular carcinoma]. (2013) (11)
‘Stem-like’ precursors are the fount to sustain persistent CD8+ T cell responses (2022) (11)
[COVID-19-Response - Strategies of the Task-Force Coronavirus and experiences upon implementation in the management of 115 cases at the University Medical Center Freiburg]. (2020) (10)
HCV research 20 years after discovery: a summary of the 16th international symposium on hepatitis C virus and related viruses. (2010) (10)
[Hepatocellular carcinoma - from immunobiology to immunotherapy]. (2012) (10)
Methodologies for the Analysis of HCV-Specific CD4+ T Cells (2015) (10)
Mutational escape from cellular immunity in viral hepatitis: variations on a theme. (2021) (9)
Outcome of Antiviral Immunity in the Liver Is Shaped by the Level of Antigen Expressed in Infected Hepatocytes (2018) (9)
Addressing the next challenges: A summary of the 22nd international symposium on hepatitis C virus and related viruses. (2016) (9)
Neoantigens as potential vaccines in hepatocellular carcinoma (2022) (9)
Over-the-scope clips are cost-effective in recurrent peptic ulcer bleeding (2019) (9)
Acute infection with a single hepatitis C virus strain in dialysis patients: Analysis of adaptive immune response and viral variability. (2009) (9)
Deep Spatial Profiling of COVID-19 Brains Reveals Neuroinflammation by Compartmentalized Local Immune Cell Interactions and Targets for Intervention (2020) (9)
Resection of a large rectal polyp with the simultaneous combination of snare polypectomy and full-thickness resection device resection (2015) (9)
Severe Hepatic Encephalopathy after Transjugular Intrahepatic Portosystemic Shunt ( TIPS ) : Value of Shunt Reduction and Occlusion (2017) (9)
54 COMPLETELY INDIVIDUALIZED TREATMENT DURATIONS (24, 30, 36, 42, 48, 60 OR 72 WEEKS) WITH PEGINTERFERON-ALFA-2B AND RIBAVIRIN IN HCV GENOTYPE 1-INFECTED PATIENTS (INDIV-2 STUDY) (2010) (9)
Interferon lambda 4 impairs hepatitis C viral antigen presentation and attenuates T cell responses (2021) (8)
Impact of NAFLD on clinical outcomes in hepatocellular carcinoma treated with sorafenib: an international cohort study (2021) (8)
Immunotherapy and therapeutic vaccines for chronic HBV infection. (2021) (8)
Adjuvant Transjugular Variceal Occlusion at Creation of a Transjugular Intrahepatic Portosystemic Shunt (TIPS): Efficacy and Risks of Bucrylate Embolization (2019) (8)
Successful two-sided sponge pull-through treatment of anastomotic leakage following pancreaticoduodenectomy with pancreaticogastrostomy (2017) (8)
Highlights from Hepatology 2015: From Chronic Hepatitis to Hepatocellular Carcinoma (2016) (8)
Reduction of esophageal stent migration rate with a novel over-the-scope fixation device. (2022) (8)
Differential virus‐specific CD8+ T‐cell epitope repertoire in hepatitis C virus genotype 1 versus 4 (2018) (7)
Erratum: Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells (2018) (7)
MAIT be different–persisting dysfunction after DAA‐mediated clearance of chronic hepatitis C virus infection (2016) (7)
Influence of the transjugular intrahepatic portosystemic stent on firstline treatment of hepatocellular carcinoma (2013) (7)
All oral fixed-dose combination Sofosbuvir/Ledipasvir with or without Ribavirin for 12 or 24 weeks in treatment-naive genotype 1 HCV-infected patients: the phase 3 ION-1 study (2014) (7)
CD4+ T cell responses in human viral infection: lessons from hepatitis C. (2020) (7)
Prognostic Value of the CLIF‐C AD Score in Patients With Implantation of Transjugular Intrahepatic Portosystemic Shunt (2021) (7)
Trailblazing Precision Medicine in Europe: a joint view by Genomic Medicine Sweden and the Centers for Personalized Medicine, ZPM, in Germany. (2021) (6)
Memory vs memory‐like: The different facets of CD8+ T‐cell memory in HCV infection (2018) (6)
Toll like receptor 7 and hepatitis C virus infection. (2007) (6)
Treatment-stage migration maximizes survival outcomes in patients with hepatocellular carcinoma treated with sorafenib: an observational study (2017) (6)
Unique and common features of innate-like human V[delta]2+ [gamma][delta]T cells and mucosal-associated invariant T cells (2018) (6)
54 Endoscopic Full-Thickness Resection in the Colorectum Using an Over-the-Scope Device - Interim Results of a Prospective Multicenter Study (2016) (5)
Tracking cccDNA in chronic HBV infection (2004) (5)
Antiviral Therapy in Hepatitis B Virus-Associated Liver Cirrhosis (2015) (5)
For whom the interferons toll - TLR7 mediated boosting of innate and adaptive immunity against chronic HBV infection. (2018) (5)
Ribavirin ante portas: uptake transporters into hepatocytes dissected. (2010) (5)
Phase II HEPANOVA trial of tumor treating fields concomitant with sorafenib for advanced hepatocellular carcinoma. (2019) (5)
End of the story: direct-acting antiviral agents are not associated with recurrence of hepatocellular carcinoma (2021) (5)
Comprehensive analysis of the α-Fetoprotein specific CD8+ T cell responses in patients with hepatocellular carcinoma (2008) (5)
SYNERGISM OF TAPASIN AND HLA IN RESOLVING HCV INFECTION (2013) (5)
[Hepatology 2009]. (2009) (5)
Discordance of hepatitis B vaccination policies for healthcare workers between the USA, the UK, and Germany (2019) (5)
Adaptive Subsets Limit the Anti-Tumoral NK-Cell Activity in Hepatocellular Carcinoma (2021) (5)
Immune responses against HCV‐NS3 after accidental infection with HCV‐NS3 recombinant vaccinia virus (2007) (4)
[Complications of liver cirrhosis - pharmaceutical versus interventional therapy]. (2019) (4)
Adaptive Immune Responses, Immune Escape and Immune-Mediated Pathogenesis during HDV Infection (2022) (4)
Kill, control, or escape: Immune responses in viral hepatitis (2016) (4)
Endoscopic submucosal dissection of an esophageal granular cell tumor (2019) (4)
The cyclophilin-inhibitor alisporivir stimulates antigen presentation thereby promoting antigen-specific CD8+ T cell activation (2016) (4)
Rapid and stable mobilization of fully functional spike-specific CD8+ T cells preceding a mature humoral response after SARS-CoV-2 mRNA vaccination (2021) (4)
Vaccine‐induced hepatitis C virus‐specific CD8+ T cells do not always help (2015) (4)
Endoscopic full-thickness resection and its treatment alternatives in difficult-to-treat lesions of the lower gastrointestinal tract: a cost-effectiveness analysis (2020) (4)
Sorafenib Promotes Graft-Versus-Leukemia Activity in Mice and Humans through IL-15 Production in Leukemia Cells (2016) (4)
Hepatozelluläres Karzinom: neue multimodale Therapiekonzepte (2018) (4)
[Genome-wide association studies]. (2011) (4)
Standardtherapie der chronischen Hepatitis B (2006) (3)
[Therapy of hepatitis B]. (2006) (3)
[The hepatocellular carcinoma: alternative therapeutical strategies]. (2007) (3)
Addition of pegylated interferon alfa-2a to an ongoing nucleos(t) ide treatment accelerates decrease of HBs-antigen levels in patients with chronic hepatitis B: Results from the PADD-ON study (2018) (3)
Fatal ulcerative enteritis of the small intestine in a patient with ulcerative colitis treated with vedolizumab (2017) (3)
ERAP 1 allotypes shape the epitope repertoire of virus-specific CD 8 + T cell responses in acute hepatitis C virus infection Graphical (2019) (3)
[Hepatitis B and C: from molecular virology to new antiviral therapies (part 2)]. (2014) (3)
642 INDIVIDUALIZED TREATMENT DURATION WITH PEGINTERFERON-ALFA-2B AND RIBAVIRIN FOR 24, 30 OR 36 WEEKS IN HCV GENOTYPE1-INFECTED PATIENTS WITH UNDETECTABLE HCV-RNA EARLY DURING THERAPY (INDIV-2 STUDY) (2009) (3)
Abnormally differentiated CD 4 1 or CD 8 1 T cells with phenotypic and genetic features of double negative T cells in human Fas de fi ciency (2014) (3)
Immunity to hepatitis C virus infection: Update 2007 (2007) (3)
CD8+ T-cell differentiation in chronic HCV infection (2011) (3)
NKp46+ expression on NK cells as a biomarker for liver pathology and IFN-responiveness in HCV infection (2013) (3)
Comparison of the Covered Self-Expandable Viatorr CX Stent with the Covered Balloon-Expandable BeGraft Peripheral Stent for Transjugular Intrahepatic Portosystemic Shunt (TIPS) Creation: a Single-Centre Retrospective Study in Patients with Variceal Bleeding (2022) (3)
Ischemic Duodenal Ulceration after Transarterial Chemoembolization for Hepatocellular Carcinoma: A Case Report (2018) (3)
[Hepatitis B and C: From molecular virology to new antiviral therapies (part 1)]. (2014) (3)
Over‐the‐scope clip versus transcatheter arterial embolization for refractory peptic ulcer bleeding—A propensity score matched analysis (2021) (3)
Validation of color Doppler ultrasound and computed tomography in the radiologic assessment of non-malignant acute splanchnic vein thrombosis (2021) (3)
High-Fructose Diet Alters Intestinal Microbial Profile and Correlates with Early Tumorigenesis in a Mouse Model of Barrett’s Esophagus (2021) (3)
Karrierewege in der Hochschulmedizin in Deutschland (2009) (3)
[Clinical management of patients with new diagnosis of liver cirrhosis]. (2019) (3)
[Career path in German university medicine]. (2009) (3)
[The role of the virus specific T-cell response in acute and chronic HBV and HCV infection]. (2004) (3)
A Comprehensive Analysis of the Impact of HIV on HCV Immune Responses and Its Association with Liver Disease Progression in a Unique Plasma Donor Cohort (2016) (3)
Efficacy of Stereotactic Body Radiotherapy in Patients With Hepatocellular Carcinoma Not Suitable for Transarterial Chemoembolization (HERACLES: HEpatocellular Carcinoma Stereotactic RAdiotherapy CLinical Efficacy Study) (2021) (3)
[Cure of chronic Hepatitis B and C: vision versus reality]. (2015) (3)
Characterization of pre-existing and induced SARS-CoV-2-specific CD8+ T cells (2020) (3)
Serological diagnosis of early HCC in NASH: A German multicenter study (2018) (3)
[Hepatology 2010]. (2010) (3)
Toward a Better Understanding of Hepatocellular Carcinoma Immune Infiltrates (2019) (3)
[30 Years of Transjugular Intrahepatic Portosystemic Shunt (TIPS): casting a retrospective glance and future perspectives]. (2020) (3)
[Direct antiviral treatment strategies in chronic hepatitis C]. (2012) (2)
[Structured Career Pathways in the University Medicine - From Promotion to Clinician Scientist Programs]. (2019) (2)
Differences in the source sequence of two HCV genotype 1b outbreaks within immunodominant CD8 epitopes are associated with differential outcome (2010) (2)
[Viral anti-interferon strategies: mechanisms and clinical impact]. (2003) (2)
iNKT cells in chronic HBV: a balancing act (2016) (2)
[Acute hepatitis C. Therapy with interferon alpha-2b]. (2002) (2)
Is Sorafenib an acceptable treatment possibility for patients with advanced hepatocellular carcinoma (2012) (2)
Balance lost: T cell immunity in progressive HBV infection (2014) (2)
[A case of idiopathic postinfantile giant cell hepatitis treated with a calcineurin inhibitor]. (2021) (2)
Double-scope resection of a large duodenal polyp (2015) (2)
Success of immune checkpoint blockade therapies – mechanisms and implications for hepatology (2019) (2)
Bulevirtide treatment of hepatitis D in Germany: multicentre real-world experience (2022) (2)
Role of Immunomodulators in Functional Cure Strategies for HBV (2020) (2)
[T-cell response against viruses. A new non-cytotoxic antiviral strategy]. (2009) (2)
[T cell response to hepatitis B and C: from viral elimination to hepatocellular carcinoma]. (2002) (2)
Current status of endoscopic full‐thickness resection with the full‐thickness resection device (2022) (2)
Mechanisms of CD8+ T cell failure in chronic hepatitis E virus infection. (2022) (2)
Use of the full-thickness resection device (FTRD) to prevent bleeding after colonic polypectomy in a patient with a left ventricular assist device (2017) (2)
[Hepatocellular Carcinoma: therapeutic options 2015]. (2015) (2)
the existence of different memory T cell subsets in the peripheral blood and liver 2 3 (2006) (2)
High-dimensional profiling reveals Tc17 cell enrichment in active Crohn’s disease and identifies a potentially targetable signature (2022) (2)
Endoskopische Vollwandresektion im Kolorektum mit dem Full-Thickness Resection Device (FTRD): Eine prospektive multizentrische Studie („WALL RESECT“) (2016) (2)
Hepatitis B vaccine and NK cells: a new player in memory (2020) (2)
The protective effect of HLA-B27 in hepatitis C virus infection requires presence of a genotype-specific immunodominant CD8+ T cell epitope (2009) (2)
Management of Portal/Mesenteric Vein Thrombosis (2014) (2)
Granulocyte colony‐stimulating factor (G‐CSF) may stimulate HIV‐replication during cytostatic chemotherapy (1998) (2)
SARS-CoV-2 specific T cells induced by both SARS-CoV-2 infection and mRNA vaccination broadly cross-recognize omicron (2022) (2)
[Chronic hepatitis B virus infection: current and future treatment strategies]. (2022) (2)
Blood reelin in the progression of chronic liver disease. (2021) (2)
337 MXA gene expression as a sensitive marker for IFN bioactivity and neutralizing antibodies in chronic hepatitis C virus infection (2003) (2)
Lost in Inflammation: The Functional Conversion of Regulatory T Cells in Acute Hepatitis A Virus Infection. (2018) (2)
Outcome of anti-viral immunity in the liver is shaped by the level of antigen expressed in infected hepatocytes (2018) (2)
Editorial: is proton pump inhibitor use associated with worse outcomes in patients with liver abscesses? Authors’ reply (2018) (1)
Implantation of transjugular intrahepatic portosystemic shunt (TIPS): indication and patient selection (2022) (1)
[Jaundice in an HIV-positive pregnant woman]. (2008) (1)
[Immunopathogenesis of viral hepatitis]. (2007) (1)
SARS-CoV-2-Specific T Cell Responses in Immunocompromised Individuals with Cancer, HIV or Solid Organ Transplants (2023) (1)
[How to do: Radiofrequency thermal ablation]. (2015) (1)
Blood cyclic guanosine monophosphate levels as potential marker of portal hypertension in patients with liver cirrhosis (2021) (1)
Immune-mediated Hepatitis associated with SARS-CoV-2 mRNA vaccination (2022) (1)
Dominance of cytolytic effector functions in hepatitis B virus-specific CD8+ T cell and NK cell mediated antiviral efficacy using hepatitis B virus infected hepatocytes overexpressing human sodium taurocholate cotransporting polypeptide (2014) (1)
Akute Hepatitis C Therapie mit Interferon α-2b (2002) (1)
Exhaustion of CD39-expressing CD8+ T cells in Crohn's disease is linked to clinical outcome. (2022) (1)
The Immune Response to HCV in Acute and Chronic Infection (2013) (1)
Another important step toward a prophylactic vaccine against hepatitis C (2022) (1)
Correction: Impact of age on sorafenib outcomes in hepatocellular carcinoma: an international cohort study (2021) (1)
Virushepatitis A–E (2021) (1)
An uncommon presentation of a common pathogen (2015) (1)
[COVID-19 associated pneumonia despite repeatedly negative PCR-analysis from oropharyngeal swabs]. (2020) (1)
Immunopathology caused by impaired CD8+ T‐cell responses (2022) (1)
[Cellular immune response in Hepatitis C infection: role of CD154 expression and clinical relevance]. (2011) (1)
[Chronic hepatitis B]. (2008) (1)
Rheumatological Patients are at Risk of Chronic HEV Infection: A Multicentric European Study (2016) (1)
[Best supportive care of hepatocellular carcinoma]. (2004) (1)
Abstract CT186: HEPANOVA: Interim safety analysis from a phase 2 study of Tumor Treating Fields (TTFields, 150 kHz) concomitant with sorafenib in advanced hepatocellular carcinoma (HCC) (2020) (1)
A rare cause of upper GI bleeding in a critically ill patient (2015) (1)
ERAP1 allotypes impact the epitope repertoire of virus-specific CD8+ T cell responses in acute hepatitis C virus infection (2019) (1)
Differenzial functional enhancement of HBV-specific CD8+ T cell upon inhibitory receptor blockade (2013) (1)
IL28B genotype and hepatitis C virus specific T cell response (2011) (1)
Postgraduate Course: Integrating Basic Science into Clinical Practice (2010) (1)
Bridge over troubled water: Protection against hepatitis C virus persistence? (2002) (1)
Virushepatitis – wann daran denken? (2019) (1)
2008 DOSE-RANGING, THREE-DAY MONOTHERAPY STUDY OF THE HCV NS3 PROTEASE INHIBITOR GS-9256 (2010) (1)
Add on Interferon-Alpha-2a for the treatment of hbeag negative Hepatitis B patients receiving effective nucleos (t)ide therapy: interim results of the prospective multicentre padd-on trial (2016) (1)
T-Zell-Antwort gegen Viren – Eine neue nicht-zytotoxische antivirale Strategie (2009) (1)
Metabolic properties of epigenetically regulated adaptive versus conventional NK cells are conserved in chronic viral hepatitis (2017) (1)
Long-term persistence of HCV resistance-associated substitutions after DAA treatment failure. (2022) (1)
Hierarchy of inhibitory receptor expression by Hepatitis B Virus (HBV)-specific CD8+ T cells in chronic HBV infection (2012) (1)
[Hepatitis C with fatigue and polyneuropathy]. (2010) (1)
Capturing adaptive immunity against SARS-CoV-2 in patients with cancer (2021) (1)
Prediction of clinical outcome in advanced hepatitis C-associated liver disease: identification of patients at the highest need for antiviral treatment and surveillance (2014) (1)
[Cholestatic liver diseases]. (2011) (1)
International multi-center experience of transjugular intrahepatic portosystemic shunt implantation in patients with common variable immunodeficiency. (2021) (1)
Reply: Freiburg index of post-TIPS survival (FIPS) a valid prognostic score in patients with cirrhosis but also an advisor against TIPS? (2021) (1)
Erratum: Tuning a cellular lipid kinase activity adapts hepatitis C virus to replication in cell culture (2017) (1)
[Therapy of chronic hepatitis B and C virus infections in the clinical practice]. (2012) (1)
Ribavirin in Acute Hepatitis E Infection in Patients with Gynecological Cancer: A Case Series (2018) (1)
T cell exhaustion dynamics are linked to clinical outcomes in Hepatocellular Carcinoma (2020) (0)
[Cholestatic liver disease]. (2016) (0)
Case Series: Convalescent Plasma Therapy for Patients with COVID-19 and Primary Antibody Deficiency (2021) (0)
726 EVALUATION OF THE IMPACT OF BARE-METAL STENT TIPS ON OVERALL SURVIVAL IN PATIENTS WITH HEPATOCELLULAR CARINOMA (HCC) (2012) (0)
[Pancreatic diseases]. (2021) (0)
Seltene Escapemutationen in einem HLA-B27 restringierten CD8+ T-Zell-Epitop erfordern kompensatorische Mutationen (2010) (0)
Author Correction: Auto-aggressive CXCR6+ CD8 T cells cause liver immune pathology in NASH (2021) (0)
Progression of NAFLD and NASH is mediated by proinflammatory tissue-resident T cells (2020) (0)
Stereotactic Body Radiotherapy vs Transarterial Chemoembolization In Locally Advanced Hepatocellular Carcinoma (HERACLES: Hepatocellular Carcinoma Stereotactic Radiotherapy Clinical Efficacy Study) (2020) (0)
Frequency Responses Is Linked to Naïve-Precursor T Cell + Hepatitis C Virus-Specific CD 8 Immunodominance of HLA-A 2-Restricted (2011) (0)
783 HBV-SPECIFIC CD8+ T CELLS AND NK CELLS MEDIATE THEIR ANTIVIRAL EFFECT PRIMARILY VIA PERFORIN/GRANZYME DEPENDENT CYTOLYSIS (2012) (0)
Impact of duodenal-jejunal bypass liner (DJBL) on NAFLD in patients with obesity and type 2 diabetes mellitus. (2022) (0)
[Structured approach with liver cirrhosis]. (2019) (0)
Pankreaserkrankungen (2021) (0)
[Autoimmune Hepatitis - What is important for clinical practice?] (2022) (0)
P0479 : Naive-like CD8+ T cells specific for subdominant hepatitis B virus epitopes are present in chronically infected patients (2015) (0)
[Cholestatic liver diseases: diagnosis and therapy of primary biliary cirrhosis]. (2002) (0)
Over-The-Scope Clips (OTSC) versus Transarterial Angiographic Embolisation (TAE) as salvage therapy for refractory peptic ulcer bleeding - a propensity score matched analysis (2020) (0)
O.173 Virus-host interactions during the first steps of viral infection: host cell responses induced by cellular binding of hepatitis C virus-like particles (2006) (0)
[Cholestatic liver diseases]. (2004) (0)
Chronic HBV Infection Drives Expansion of Adaptive NK Cells (2016) (0)
Unusual endoscopic treatment of recurrent cough and pneumonia (2018) (0)
Metabolic programming of exhausted CD8+ T cells in chronic viral hepatitis (2019) (0)
P92 CD161+ γ-δ T cells: defining their role in patients with and without chronic hepatitis C (2011) (0)
The spatial distribution and detailed composition of infiltrating immune cells define autoimmune- and checkpoint-therapy associated hepatitis (2022) (0)
CD8+ T CELL RESPONSE IN ACUTE HCV INFECTION (2014) (0)
45 RAPID AND EFFICIENT ANTIGEN PROCESSING AND PRESENTATION OF A PROTECTIVE AND IMMUNODOMINANT HLA-B*27-RESTRICTED HEPATITIS C VIRUS-SPECIFIC CD8+ T CELL EPITOPE (2012) (0)
Author response: Bystander hyperactivation of preimmune CD8+ T cells in chronic HCV patients (2015) (0)
Single cell RNAsequencing derived signature of hepatocyte de-differentiation predicts development of hepatocellular carcinoma in patients with liver cirrhosis (2022) (0)
56 Scavenger receptor class B type i mediates uptake and cross-presentation of hepatitis C virus by human dendritic cells (2006) (0)
Perspectives for novel therapeutic concepts in hepatocellular carcinoma targeting the stromal and innate immune microenvironment (2022) (0)
CD4 T cell immunity to HEV-infection is characterized by sustained capsid-specific responses that correlate with neutralizing antibodies (2022) (0)
Regulatory T cells suppress virus-specific CD8+ T cells in chronically hepatitis C virus infected patients (2004) (0)
Detection of naïve hepatitis C virus-specific CD8+ T cells in chronically infected patients (2013) (0)
P078 Vitamin D concentrations affect the composition of T-lymphocyte subsets and proinflammatory cytokine production in patients with inflammatory bowel disease (2018) (0)
Evolving treatments of virus-associated HCC: new targets and drugs. (2010) (0)
P0491 : Identification of CD8+ T-cell epitopes specific for hepatitis C virus genotype 4 (2015) (0)
PS-032-Impact of antigen recognition on memory-like HCV-specific CD8+ T-cells (2019) (0)
[Preclinical and clinical management of patients with acute gastrointestinal bleeding]. (2022) (0)
372 HIERARCHY OF INHIBITORY RECEPTOR EXPRESSION BY HEPATITIS B VIRUS (HBV)-SPECIFIC CD8+ T CELLS IN CHRONIC HBV INFECTION (2013) (0)
Die Hepatitis-E-Virus-Infektion (2020) (0)
1350 HOST-SPECIFIC FACTORS INDEPENDENT OF IL28B GENOTYPE PREDICTING TREATMENT OUTCOME OF INDIVIDUALIZED THERAPY IN PATIENTS WITH CHRONIC HEPATITIS C GENOTYPE 1 INFECTION (2011) (0)
Hepatic decompensation after transarterial radioembolization (TARE) – a retrospective analysis of risk factors and outcome of patients with HCC (2022) (0)
SAT-381-TAA-specific CD8+ T-cell responses are inefficiently induced in hepatocellular carcinoma (2019) (0)
The Role of Novel Prognostic Scores for Patients With Hepatocellular Carcinoma (2017) (0)
[Correction: Colorectal carcinoma]. (2021) (0)
P140 MODELLING THE LIVER IMMUNE MICROENVIRONMENT: FACTORS THAT DEFINE ANTIVIRAL ACTIVITY OF T CELLS (2014) (0)
Abstract CT175: HEPANOVA Phase II study design for advanced hepatocellular carcinoma: Tumor treating fields concomitant with sorafenib (2019) (0)
473 ENDOSCOPIC FULL-THICKNESS RESECTION IN COLORECTAL CANCER (2019) (0)
Combined OX40 stimulation and PD-L1 blockade reinforce HBV-specific CD4 T cell responses (2019) (0)
Enforced cytotoxic signature of HBV pol455-specific CD8 T cells in chronic HBV infection (2022) (0)
[The patient as partner -- observations regarding a respectful relationship with sick people]. (2005) (0)
Type I Interferons promote maintenance and function of follicular T helper cells in vitro (2019) (0)
Th1-Biased Hepatitis C Virus-Specific Follicular T Helper-Like Cells Effectively Support B Cells After Antiviral Therapy (2021) (0)
VΔ1 T Cells Differentiate into Cytotoxic Effector Cells in Chronic Viral Hepatitis (2016) (0)
O104 CYTOLYTIC EFFECTOR FUNCTIONS PREDOMINATE IN CD8+ T-CELL AND NK-CELL MEDIATED INHIBITION OF VIRAL REPLICATION IN HBV INFECTED HEPATOCYTES OVEREXPRESSING SODIUM TAUROCHOLATE COTRANSPORTING POLYPEPTIDE (2014) (0)
Incidence and severity of immune-related hepatitis after dual checkpoint therapy is linked to younger age independent of herpes virus immunity (2022) (0)
Analysis of HCV-specific CD8+ T-cell cytolytic effector functions and their contribution to antiviral efficacy using a novel immunological model (2010) (0)
Persistence of a transcriptional chronic scar on HCV-specific CD8+ T cells after DAA-mediated antigen removal (2020) (0)
An international cohort study investigating the impact of age on clinical outcome in patients with hepatocellular carcinoma treated with sorafenib. (2020) (0)
[Virus Hepatitis in Transition]. (2019) (0)
Immune‐mediated pathology as a consequence of impaired immune reactions: the IMPATH paradox (2022) (0)
CD154 expression reveals the presence of dysfunctional virus-specific CD4+ T cells during chronic HCV infection (2008) (0)
Fate of HDV-specific CD8+ T cells during bulevirtide monotherapy in patients with chronic hepatitis delta (2022) (0)
208 ANALYSIS OF CD8+ T-CELL RESPONSES TO AFP, GLYPICAN-3, MAGE-A1 AND NY-ESO-1 IN PATIENTS WITH HEPATOCELLULAR CARCINOMA REVEALS A CLEAR HIERARCHY AND IMMUNODOMINANCE (2011) (0)
T-Cell Response to Hepatitis B and C Virus: Lessons from the Chimpanzee Model (2005) (0)
[RNA interference as antiviral strategy]. (2008) (0)
792 HBV-HCV COINFECTION: A NOVEL MODEL SYSTEM REVEALS INSIGHTS INTO IMMUNOLOGICAL MECHANISMS OF VIRAL INTERFERENCE (2012) (0)
An alternative model for prediction of transplant-free survival in patients with implantation of transjugular intrahepatic portosystemic shunt (TIPS): The Freiburg risk score (2019) (0)
Risk-stratified management of advanced hepatocellular carcinoma (HCC) (2018) (0)
Comparison of different inhibitory pathways in hepatitis B virus-specific CD8+ T cell exhaustion (2014) (0)
[Molecular biology in internal medicine. Report of the 24th Ludwig Heilmeyer Symposium of the Society for Progress in Internal Medicine]. (1997) (0)
[Antibiotic therapy done right]. (2020) (0)
Cytokine patterns of newly identified HEV-specific CD4 T cell epitope (2020) (0)
[Suppressor T-cells: immunologic regulator cells and clinical perspectives]. (2004) (0)
HCV-specific CD4 T cells show strong Tfh functionality after DAA-mediated viral clearance (2020) (0)
1349 VIROLOGIC RELAPSE IS HIGHLY CORRELATED WITH RESPONSE AT WEEK 4 AND 12 BUT NOT WITH IL28B GENOTYPE IN HCV GENOTYPE 1-INFECTED PATIENTS TREATED WITH PEG-INTERFERON/RIBAVIRIN (2011) (0)
Parallel in vitro expansion of human hepatitis C virus specific FoxP3- effector memory and FoxP3+ regulatory CD8+ T cells on recognition of the same antigen (2007) (0)
PO-1050: SBRT in liver cancer versus TACE. A prospective, non-randomised observational trial (HERACLES) (2020) (0)
Efficacy and safety of transjugular intrahepatic portosystemic shunt in patients with hepatocellular carcinoma: a single center experience (2014) (0)
The transcription factor TOX controls differentiation and maintenance of CD8 T-cells in chronic infections. (2019) (0)
Ex vivo analysis of HCV-specific CD8+ T cell antiviral efficacy using a novel immunological model (2011) (0)
893 VARIATIONS OF VITAMIN D LEVELS IN GENOTYPE 1HEPATITIS C PATIENTS UNDERGOING ANTIVIRAL THERAPY CORRELATE WITH STAGE OF FIBROSIS BUT NOT WITH TREATMENT OUTCOME (2012) (0)
Analysis of HLA-B27-Restricted Hepatitis C Virus-Specific CD8+ T Cell Responses in Acute Resolving Hepatitis (2005) (0)
Magnitude and functionality of HEV-specific CD8+ and CD4+ T cell responses in asymptomatic blood donors resemble those in acute and symptomatic patients (2020) (0)
[Hepatic amyloidosis as a rare differential diagnosis of progressive liver failure]. (2016) (0)
Sa1780 Comprehensive T Helper Cell Profiling Reveals Concomitant Upregulation of Regulatory T Cells and TH17 Cells in Active Inflammatory Bowel Disease (2013) (0)
Reduced mortality for over-the-scope clips (OTSC) versus surgery for refractory peptic ulcer bleeding: a retrospective study (2022) (0)
PO-0811 SBRT compared to sorafenib in locally advanced hepatocellular carcinoma: a propensity score analysis (2019) (0)
Frequency Is Linked to Naïve-Precursor T Cell + Hepatitis C Virus-Specific CD8 Immunodominance of HLA-A2-Restricted (2014) (0)
P172 COMPARISON OF DIFFERENT IMMUNOREGULATORY PATHWAYS IN HEPATITIS B VIRUS-SPECIFIC CD8+ T-CELL FAILURE (2014) (0)
Naturally occurring, tumor-specific CD8+ T cells in patients with hepatocellular carcinoma display a clear immunodominance (2012) (0)
[Autoimmune diseases of the gastrointestinal tract]. (2022) (0)
MAIT Cells in Viral Hepatitis and Liver Diseases. (2021) (0)
Abstracts of the Scientific Meeting of the Bayliss & Starling Society. Guest Editor: Keith D. Buchanan, Belfast, Northern Ireland (1999) (0)
[Endoscopic Ultrasound-Guided Fine Needle Aspiration]. (2017) (0)
[Kaposi sarcoma: a virus-induced tumor?]. (1997) (0)
Viral escape contributes to the failure of hepatitis D virus (HDV)-specific CD8+ T cells and drives population-level evolution of HDV (2019) (0)
Scavenger Receptor Class B Is Required for Hepatitis C Virus Uptake and Cross-Presentation by Human Dendritic Cells (cid:1) (2008) (0)
Soft-Tissue Infection with Abscesses Following a Cat Bite on the Forearm. (2021) (0)
Full breadth analysis of AFP-specific CD8+ T cells in patients with hepatocellular carcinoma in the blood and in the liver (2008) (0)
[Unusual cause of a PCT-elevation]. (2021) (0)
[Viral Hepatitis: When to be Considered in Clinical Routine?] (2019) (0)
Hepatic decompensation after transarterial radioembolization: A retrospective analysis of risk factors and outcome in patients with hepatocellular carcinoma (2022) (0)
Differential Contribution of Progenitor and Terminal Subsets of Exhausted CD8+ T Cells in Chronic HBV versus HCV Infection (2016) (0)
FRI-138-HBVcore-versus HBVpolymerase-specific CD8+ T cells differ in chronically HBV-infected patients (2019) (0)
[784] EXHAUSTION OF VIRUS SPECIFIC CD4+ T CELLS DURING ACUTE HEPATITIS C (2007) (0)
Impact of tumor markers in diagnosis of patients with hepatocellular carcinoma (HCC) and their clinicopathologic correlation: an interim analysis (2012) (0)
[Urinary and fecal incontinence]. (2022) (0)
Reply: TIPS and liver transplantation should always be discussed together. (2021) (0)
Characterization and Functional Modulation of HBV-Specific CD4+ T Cell Responses (2015) (0)
Blood reelin levels in the progression of chronic liver disease (2020) (0)
Excellent local control and tolerance profile after stereotactic body radiotherapy of advanced hepatocellular carcinoma (2017) (0)
Fritz von Weizsäcker 1960-2019: An exceptional physician-scientist. (2020) (0)
P071 Intestinal CD8+ T cell exhaustion is linked to disease activity in ulcerative colitis (2022) (0)
Determinants of CD8+ T cell exhaustion during chronic hepatitis C virus infection (2010) (0)
P-215 phase 2 HEPANOVA study of tumor treating fields (TTFields, 150 kHz) concomitant with sorafenib in advanced hepatocellular carcinoma (HCC): Interim safety analysis (2020) (0)
A protective HLA-B*27 restricted epitope contributes to viral control in chronic HCV infection despite presence of viral escape mutations and is characterized by a unique T cell phenotype (2014) (0)
Identification of CD8+ T-cell epitopes specific for hepatitis C virus genotype 4 (2015) (0)
Hepatitis C Virus (Flaviviridae): Host Immune Responses to Hepatitis C Virus (2009) (0)
[Fibroscan of the liver]. (2015) (0)
IL-3 PHYLOGENETIC ANALYSIS OF EUPHORBIA PALLASII USING 5 . 8 S RIBOSOMAL GENE , UNIVERSAL PRIMER SET OF THE ITS REGION NUCLEAR DNA SEQUENCE (2017) (0)
Editorial: acute non‐cirrhotic and non‐malignant portal vein thrombosis––who should be candidates for interventional treatment? Authors’ reply (2020) (0)
286 DOMINANT CYTOLYTIC ANTIVIRAL EFFECTOR FUNCTIONS IN A NOVEL IMMUNOLOGICAL MODEL OF HBV INFECTION (2011) (0)
[CD8(+) T cell differentiation in viral infections]. (2006) (0)
The breadth of CD8+ T cell responses in chronic and resolved HBV infection (2015) (0)
Sa1177: HIGH FAT DIET SHAPES GUT MICROBIOME AND ACCELERATES PROGRESSION FROM BARRETT ESOPHAGUS TO ADENOCARCINOMA VIA SYSTEMIC BILE ACIDS (2022) (0)
Rapid communications Transfusion-transmitted hepatitis E in Germany , 2013 (2014) (0)
HLA-A26 restricted HCV-specific CD8+ T cell responses in acute and chronic HCV infection (2006) (0)
Hepatitis C Virus (HCV) Sequence Variation Induces an HCV-Specific T-Cell Phenotype Analogous to Spontaneous Resolution (2011) (0)
483 IMPORTANCE OF HCV RNA ASSAY CHARACTERISTICS AND DIFFERENCES BETWEEN ASSAYS FOR RESPONSE GUIDED THERAPY OF CHRONIC HEPATITIS C (2011) (0)
Persistence of hepatitis C after homolgous monoclonal re-challenge associated with the emergence of new virus variants (2003) (0)
NS5A resistance patterns and treatment outcomes in DAA-naive genotype 1a chronic hepatitis C patients with and without baseline resistance-associated substitutions (2018) (0)
Induction of MxA Gene Expression by Inﬂuenza A Virus Requires Type I or Type III Interferon Signaling (cid:1) (2007) (0)
[Hepatology: from basic science to the clinic]. (2012) (0)
Hepatitis B Virus-Infected HepG2 hNTCP Cells Serve as a Novel Immunological Tool To Analyze the Antiviral Efﬁcacy of CD8 (cid:2) T Cells In Vitro (2015) (0)
SARS-CoV-2-specific adaptive immune response after mRNA vaccination in liver transplanted patients (2022) (0)
Inflammation and Cancer: Falk Workshop, Hamburg, January 2012 (2012) (0)
Role of the Immune System in Hepatocellular Carcinoma: Implications for Existing and Novel Therapies (2016) (0)
[Colorectal carcinoma]. (2021) (0)
Vaccine-Induced HCV-Specific CD8+ T Cell Response Restricted by the Protective HLA Allele B*27: Broad Cross-Recognition of Evolving Viral Variants (2016) (0)
Intrahepatic compartmentalization of IL-17-producing CD4+ and CD8+ T cells in chronic HCV infection (2009) (0)
Nivolumab plus palliative Chemotherapie (2021) (0)
Mo1883 – Clinical Response to Ustekinumab in Crohn’s Disease is Linked to a Dose Dependent Reduction of T Follicular Helper Cells (2019) (0)
3 POPULATIONAL ANALYSIS REVEALS A LINK BETWEEN COMPLEX VIRAL ESCAPE FROM CD8+ T-CELL RESPONSES AND PROTECTION IN HCV INFECTION (2011) (0)
The patient as partner - clinical care respecting patient autonomy (2005) (0)
Influence of type 2 diabetes mellitus on tumour characteristics and outcomes in patients with hepatocellular carcinoma (2013) (0)
PO-0767: Local tumor control in patients with HCC treated with SBRT or TACE: a propensity score analysis (2018) (0)
Peptides and Definition of Their Peptide Molecules That Bind HLA Supertype Identification of Five Different Patr Class I (2000) (0)
P0392 : Transarterial chemoembolisation in patients with metastatic hepatocellular carcinoma (2015) (0)
Title Page / Table of Contents / Guidelines for Authors / Imprint (2014) (0)
[Diseases of the gall-bladder and bile ducts]. (2020) (0)
[Diagnosis and treatment of hepatocellular carcinoma]. (2004) (0)
Natural course and prognostic factors in patients with cholestatic liver disease – experience from a single center study (2015) (0)
Holmium laser vaporization and percutaneous removal of a migrated endothelialized biliary self-expanding metal stent (2019) (0)
Analysis of the Evolutionary Forces in an Immunodominant CD8 Epitope in Hepatitis C Virus at a Population Level (2011) (0)
Function is the key: impact of interferon on HCV-specific CD8+ T cells during acute HCV infection (2008) (0)
Survival prediction using the Freiburg index of post-TIPS survival (FIPS) in critically ill patients with acute- on chronic liver failure: A retrospective observational study (2022) (0)
Hepatitis E in Haematological Patients in Europe: A Multicentre Study (2016) (0)
HLA-B*27 subtype specificity determines the targeting of HLA-B*27 restricted HCV-specific CD8+ T cell epitopes (2013) (0)
Natural history of chronic hepatitis B virus infection (2014) (0)
Functional Mapping of Hepatitis C Virus (HCV)-Dendritic Cell Interaction Using HCV-like Particles (2005) (0)
Virushepatitis A–E (2006) (0)
Virushepatitis@@@Viral hepatitis (2006) (0)
[Therapy refractory ascites: insertion of a tunneled long-term peritoneal catheter]. (2009) (0)
90 IMMUNODOMINANCE OF HLA-A*0201 RESTRICTED HEPATITIS C VIRUS-SPECIFIC CD8+ T CELL RESPONSES IS DETERMINED BY THE NAIVE PRECURSOR FREQUENCY (2011) (0)
FRI-208-Predictors of treatment response during addition of pegylated Interferon alfa-2a to an onging nucleos (t)id treatment in chronic hepatitis B: Results from the PADD-ON trial (2019) (0)
CD161 expressing CD4+ CD25hi T cells accumulate in the liver of obese patients with NASH (2022) (0)
The Breadth of CD8+ T Cell Responses in Chronic and Resolved Hepatitis B Virus Infection (2016) (0)
Clinical Hepatology Practice in 2016: From Science to Therapy: Symposium 204, Birmingham, September 2016 (2017) (0)
Abstracts of the Annual Congress of the British Society for Immunology. December 6-10, 2010. Liverpool, United Kingdom. (2010) (0)
[Immunological T cell analyses -- current state and clinical relevance]. (2006) (0)
AFP-specific CD4+ T-cell immunity in the blood and liver of patients with Hepatocellular Carcinoma (2010) (0)
P200 SUPPRESSIVE EFFECT OF IL-10 ON THE PRIMING OF NAIVE HCV-SPECIFIC CD8+ T-CELLS (2014) (0)
Analysis of Successful Virus-Specific CD8+ T Cell Responses in acute HBV infection (2006) (0)
HLA-B27 has a dominant role in restricting strong CD8+ T cell responses and driving viral escape in hepatitis B virus infection (2012) (0)
Identification of a TSCM phenotype HCV-specific CD8+T cell response with superior functionality in chronic HCV infection [Abstract] (2014) (0)
VIRAL FITNESS COST AND T CELL CROSS-RECOGNITION LIMIT VIRAL ESCAPE WITHIN A PROTECTIVE HLA-B27 RESTRICTED HEPATITIS C VIRUS SPECIFIC CD8+T CELL EPITOPE (2008) (0)
EFFECTIVE REDUCTION OF ESOPHAGEAL STENT MIGRATION RATE WITH A NOVEL OVER-THE-SCOPE FIXATION DEVICE (STENTFIX OTSC) (2022) (0)
[Angiostatin. A biological inhibitor of tumor angiogenesis]. (1997) (0)
Hepatische Amyloidose als seltene Differenzialdiagnose bei progredientem Leberversagen (2016) (0)
Two-sided sponge (TSS) treatment - a modified endoscopic vacuum technique for anastomotic leaks and perforations in the upper gastrointestinal tract and small bowel (2020) (0)
Priming persistence of HCV (2015) (0)
CD4+ T cells don't always help (2007) (0)
Presence of naive-like HBV-specific CD8+ T cells in chronically infected patients despite ongoing viral replication (2015) (0)
[Quorum sensing: a mechanism of communication between bacteria]. (1998) (0)
The transcription factor c-Jun/AP-1 promotes liver fibrosis during non-alcoholic steatohepatitis by regulating Osteopontin expression (2019) (0)
[Serologic pitfalls in the diagnosis of hepatopathy of uncertain origin]. (2013) (0)
Restoration of Hepatitis C virus-specific CD8+ T-cell responses in patients undergoing IFN-free antiviral therapy (2014) (0)
A Memory-Like Subset Dominates the HCV-Specific CD8+ T-Cell Compartment after DAA-Mediated Antigen Removal (2016) (0)
Hepatitis C Virus (HCV) Sequence Variation Induces an HCV-Specific T-Cell Phenotype Analogous to Spontaneous Resolution (vol 84, pg 1656, 2010) (2011) (0)
Regulatory T Cells Suppress Virus-Specific CD8+ T Cell Proliferation During Chronic Hepatitis C Virus Infection (2005) (0)
Cholestatic liver diseases: primary biliary cirrhosis (2002) (0)
Comprehensive analysis of the intrahepatic virus-specific CD8+ T-cell response during chronic hepatitis C virus infection (2004) (0)
Maintenance of virus-specific CD4+ T cell responses in chronic HCV infection in blood and liver identified by antigen-specific upregulation of CD154 (2009) (0)
FRI-150-Association of the immunodominant HLA-B35:01 restricted CD8+ T cell epitope with clustered viral evolution in HBV polymerase (2019) (0)
Protection from persistent hepatitis C virus infection by HLA class I: The need for multiple escape mutations in immunodominant T cell epitopes is a common feature (2011) (0)
Clearance of chronic HCV infection leads to an expansion of a follicular T helper cell memory phenotype in HCV-specific CD4 T cells (2019) (0)
P0487 : Dominance of HLA-B restricted virus-specific CD8+ T cell epitopes in chronic HBV infection (2015) (0)
Comparison of local tumor control in patients with HCC treated with SBRT or TACE: a propensity score analysis (2018) (0)
Plasma Cyclic Guanosine Monophosphate Is a Promising Biomarker of Clinically Significant Portal Hypertension in Patients With Liver Cirrhosis (2022) (0)
Scavenger Receptor Class B Type I is a Hepatitis C Virus Receptor on Human Dendritic Cells (2006) (0)
The GALAD Score as Potential Screening Test for Hepatocellular Carcinoma in Nonalcoholic Steatohepatitis: An International Multicenter Study (2019) (0)
694 DIAGNOSTIC ACCURACY OF HCC BIOMARKERS DEPENDS ON THE ETIOLOGY OF LIVER DISEASE: AN INTERIM ANALYSIS (2012) (0)
O12 RESTORATION OF HCV-SPECIFIC CD8+ T-CELL RESPONSES WITH INTERFERON-FREE TREATMENT OF HEPATITIS C (2014) (0)
Editorial: TIPSS in patients with cirrhosis and hepatocellular carcinoma – authors' reply (2015) (0)
Evaluation of Laboratory and Sonographic Parameters for Detection of Portal Hypertension in Patients with Common Variable Immunodeficiency (2022) (0)
40 HLA-B27 HAS A DOMINANT ROLE IN RESTRICTING STRONG CD8+ T CELL RESPONSES AND DRIVING VIRAL ESCAPE IN HEPATITIS B VIRUS INFECTION (2012) (0)
Dominance of HLA-B restricted virus-specific CD8+ T cell epitopes in chronic HBV infection (2015) (0)
FRI-154-Augmentation of HBV-specific CD4 T cell responses via combined 0X40 stimulation and PD-L1 blockade (2019) (0)
Tailoring of hepatitis C virus escape from an HLA-B27 restricted CD8+ T cell epitope (2010) (0)
Proton pump inhibitor therapy is associated with reduced survival following first-time transarterial chemoembolization in patients with hepatocellular carcinoma (2020) (0)
395 Intrahepatic CD8+ T cell failure: T cell dysfunction and viral escape during chronic HCV infection (2003) (0)
Enolase represents a metabolic checkpoint controlling the differential exhaustion of virus-specific CD8+ T cells in viral hepatitis (2022) (0)
Responsiveness of HBV-specific CD8+ T cells to PD1 pathway blockade is linked to TCF1 expression (2017) (0)
Cholestatic liver diseases: primary sclerosing cholangitis (2002) (0)
P147 CD4+ T CELL EGRESS THROUGH HEPATIC EPITHELIA HAS PROFOUND IMPLICATIONS FOR PHENOTYPE AND FUNCTION (2014) (0)
Insights From Antiviral Therapy into Immune Responses to HBV and HCV Infection (2019) (0)
EASL innovation award recipient 2022: Prof. Martin Rössle. (2022) (0)
[From Molecuar to Natural Medicine]. (2018) (0)
CD161+gamma-delta T CELLS: DEFINING THEIR ROLE IN PATIENTS WITH AND WITHOUT CHRONIC HEPATITIS C (2011) (0)
TOX expression on HBV specific CD8+ T cells is linked to clinical stage of chronic HBV infection (2020) (0)
[Hepatitis B viral load as a risk factor for liver cirrhosis]. (2008) (0)
PS-028-Viral escape contributes to the failure of hepatitis D virus-specific CD8+ T-cells and drives evolution of HDV (2019) (0)
Discovery of conserved HDV-specific CD8+ T-cell epitopes in HBV/HDV infection (2021) (0)
Announcement and Erratum (1999) (0)
Contents Vol. 30, 2014 (2014) (0)
361 REGULATORY T-CELLS DIFFERENTIALLY REGULATE PROLIFERATION AND CYTOKINE PRODUCTION OF HCC-SPECIFIC CD8+ T-CELLS (2013) (0)
[Cholestatic liver diseases: diagnosis and therapy of primary sclerosing cholangitis]. (2002) (0)
The Role of Stereotactic Body Radiotherapy (SBRT) in Locally Advanced Hepatocellular Carcinoma Versus Transarterial Chemoembolization (TACE): A Prospective, Non-Randomized Observational Trial (HERACLES) (2019) (0)
Sexual dimorphism in hepatitis B and C and hepatocellular carcinoma (2018) (0)
Reply: External validation of the Freiburg index of post-TIPS survival and Freiburg index of post-TIPS survival: the first score for individual prediction and a complementary tool for risk stratification. (2021) (0)
271 HIGH EXPRESSION OF DIPEPTIDYLPEPTIDASE IV (CD26) ON INTRAHEPATIC TH17 CELLS IN INFLAMMATORY LIVER DISEASES (2011) (0)
Protection by HLA-B27 in HCV infection: role of virological and immunological factors (2008) (0)
From Viral Hepatitis to Chronic Inflammation and Liver Cancer (2019) (0)
Reduced survival in patients with proton pump inhibitor treatment following implantation of a transjugular intrahepatic portosystemic shunt (2021) (0)
[Systemic treatment for hepatocellular carcinoma]. (2003) (0)
O158 A PROTECTIVE HLA-B*27 EPITOPE CONTRIBUTES TO HCV CONTROL IN CHRONIC INFECTION DESPITE PRESENCE OF VIRAL ESCAPE MUTATIONS AND IS CHARACTERIZED BY A UNIQUE T-CELL PHENOTYPE (2014) (0)
ArgoCap - feasibility and safety of a novel over-the-scope device to facilitate endoscopic APC treatment. (2023) (0)
Boosting compromised SARS-CoV-2-specific immunity with mRNA vaccination in liver transplant recipients (2023) (0)
Boosting compromised SARS-CoV-2-specific T cell immunity in liver transplant recipients by mRNA vaccination (2023) (0)
Treating hepatitis D with bulevirtide - Real-world experience from 114 patients. (2023) (0)
Adaptive NK cells with decreased antitumor activity are expanded in HBV-associated HCC (2018) (0)
Evidence of a dysfunctional Tfh cell response after decompensation of liver cirrhosis (2018) (0)
Expansion of HCV-specific T cells with a follicular T helper cell phenotype after DAA mediated antigen removal (2018) (0)
Characterization of the HEV-specific CD8 T-cell response in acute and chronic Hepatitis E virus infection (2018) (0)
Comparison of local tumor control in patients with HCC treated with stereotactic body radiation or TACE: a propensity score analysis (2018) (0)
DOP70 High-dimensional analysis reveals a novel signature for IL-17 producing CD8 T cells in inflammatory bowel disease (2020) (0)
[Diversity in gastroenterology - A focus on inflammatory bowel diseases]. (2023) (0)
MAGE-specific CD8 T cells are not exhausted in HCC patients (2018) (0)
Subset diversification of virus-specific CD8+ T-cells in chronic HCV monoinfection and HCV/HIV coinfection (2016) (0)
Efficacy of variceal embolisation in patients with TIPS implantation: a propensity score analysis (2018) (0)
Memory-like HCV-specific CD8+ T cells retain a molecular scar after cure of chronic HCV infection (2021) (0)
P084 Clinical response to Ustekinumab in Crohn’s disease is linked to a dose-dependent reduction of T follicular helper cells (2019) (0)
The impact of ERAP1 polymorphisms on virus-specific CD8+ T cell responses in an HLA*B27+ patient with acute hepatitis C virus infection (2016) (0)
Micro-RNA Landscape of Hepatocellular Carcinoma-Derived Extracellular Vesicles (2023) (0)
Metabolic programming of exhausted CD8+ T cells in chronic viral hepatitis (2020) (0)
IL-18, CXCL-8 and CXCL-10 plasma levels decrease in patients with chronic Hepatitis C virus infection undergoing DAA therapy (2016) (0)
Major Histocompatibility Complex (MHC) Class I-associated phosphopeptides as potential targets for immunotherapy in hepatocellular carcinoma (HCC) (2016) (0)
The ALBI score: a new tool for decision making after TACE (2016) (0)
Antigen-specificity determines virus-specific CD8 T-cell exhaustion profile in chronic HBV infection (2018) (0)
HLA-B*27-restricted CD8+ T cell response against hepatitis B virus: viral escape as central mechanism of T cell failure (2021) (0)
Inefficient induction of TAA-specific CD8+ T-cell responses in hepatocellular carcinoma (2019) (0)
A TCF1 expressing memory-like population of Hepatitis C virus-specific CD8+ T cells is maintained after DAA-mediated viral elimination (2016) (0)
Long-term PPI treatment is a risk factor for acute-on-chronic liver failure in patients with advanced cirrhosis: a propensity score matched analysis (2023) (0)
MCAM is a prognostic serum biomarker in patients with liver cirrhosis and HCC (2023) (0)
Phenotypic and functional differences of HBVcore- versus HBVpolymerase-specific CD8+ T cells in chronically HBV-infected patients with low viral load (2019) (0)
The role of phosphopeptide neoantigens in cancer immunotherapy (2018) (0)
Sustained Vd1 and Vd2 T-cell profiles in chronic viral hepatitis (2016) (0)
The metabolic signature of adaptive NK cells is maintained during chronic viral hepatitis (2016) (0)
Follicular T helper cells in patients with cholestatic liver disease – a comparative study (2016) (0)
The transcription factor c-Jun/AP-1 affects non-alcoholic steatohepatitis (NASH) and liver fibrosis in a cell-type specific manner (2018) (0)
Immune escape pathways from the HBV core18-27 CD8 T cell response are driven by individual HLA class I alleles (2022) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Robert Thimme?

Robert Thimme is affiliated with the following schools:

University of Freiburg
University of Oxford
Stanford University

Robert Thimme's Academic­Influence.com Rankings

Why Is Robert Thimme Influential?

Robert Thimme's Published Works

Published Works

What Schools Are Affiliated With Robert Thimme?

Robert Thimme's AcademicInfluence.com Rankings